Catalyst Wire Dossier Catalyst Wire Dossier

Sivextro

tedizolid · Merck & Co.
Drug timelines are a Plus or Pro feature.

31 regulatory and trial events tracked for Sivextro, covering 2014-06-20 to 2026-02-27. Get the full timeline:

Most recent: FDA Approved: SIVEXTRO — Supplemental Application (Merck Sharp & Dohme LLC)

See pricing